Skip to content
20-F

Annual Report (Foreign)

RELIEF THERAPEUTICS HOLDING SA RLFTF RLFTY

0001193125-24-125218

← back to feed
Filed
Apr 30, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted FY 2023 · Dec 31, 2023 11.75M sh
Shares Diluted restated FY 2023 · Dec 31, 2022 10.57M sh
Shares Outstanding FY 2023 · Dec 31, 2023 12.54M sh
Operating Cash Flow FY 2023 · Dec 31, 2023 −17.61M
Operating Cash Flow FY 2023 · Dec 31, 2022 −24.13M
Cash And Equivalents FY 2023 · Dec 31, 2023 14.56M
Cash And Equivalents FY 2023 · Dec 31, 2022 19.24M
Cash And Equivalents FY 2023 · Dec 31, 2021 44.76M
Stockholders Equity FY 2023 · Dec 31, 2023 52.23M
Stockholders Equity FY 2023 · Dec 31, 2022 145.42M
Stockholders Equity FY 2023 · Dec 31, 2021 181.53M
Current Liabilities FY 2023 · Dec 31, 2023 6.91M
Current Liabilities FY 2023 · Dec 31, 2022 10.72M
Current Assets FY 2023 · Dec 31, 2023 18.3M
Current Assets FY 2023 · Dec 31, 2022 22.58M
Total Assets FY 2023 · Dec 31, 2023 76.39M
Total Assets FY 2023 · Dec 31, 2022 188.8M
Eps Diluted FY 2023 · Dec 31, 2023 −8.35
Eps Diluted restated FY 2023 · Dec 31, 2022 −4.81
Eps Basic FY 2023 · Dec 31, 2023 −8.35
Eps Basic restated FY 2023 · Dec 31, 2022 −4.81
Rd Expense FY 2023 · Dec 31, 2023 1.33M
Rd Expense FY 2023 · Dec 31, 2022 12.39M
Net Income FY 2023 · Dec 31, 2023 −98.18M
Net Income FY 2023 · Dec 31, 2022 −50.79M
Operating Income FY 2023 · Dec 31, 2023 −110.83M
Operating Income FY 2023 · Dec 31, 2022 −52.04M
Revenue FY 2023 · Dec 31, 2023 6.33M
Revenue restated FY 2023 · Dec 31, 2022 7.11M